CiToxLAB Scantox After working in this company for 11 years (since 2002), can you please introduce our readers to CiToxLAB Scantox? Scantox was founded in Demark as a private Danish company in 1977 and has since gone through different stages. For instance, in the mid-2000s the decision was taken that Scantox needed…
Grünenthal GmbH You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the position and how have they panned out so far? I wanted to make a change — a change for patients; a change for those…
Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…
AbbVie Austria You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a global biopharmaceutical company, which as of January 2nd is being traded on the New York Stock Exchange as an independent…
Belgium Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman (TH): Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When…
Vela Laboratories Prior to founding Vela, you worked in a number of different positions with various companies such as Baxter and Octapharma. What opportunities did you see in founding your own company? The opportunity to found Vela arose while working at Igeneon, when upper management there filed insolvency and liquidator takes care…
Eucodis Bioscience Previously you worked for a pharmaceutical company, before moving to head up Eucodis Bioscience. What was your main motivation for switching from the pharmaceutical to the industrial biotech industry? The main motivation was the portfolio of the company and that it is in biotech. Austria is not a big country…
Boston Consulting Group Austria Could you please provide an overview of your main scope of activities in Austria and the importance of healthcare and pharmaceuticals to Boston Consulting Group’s (BCG) business model and revenue? EK: BCG has been in Austria for 15 years and we are integrated into the German-Austrian system, meaning that many…
Kedrion International GmbH Prior to joining Kedrion you worked for CSL Behring for a number of years. What opportunities did you see for yourself in moving from there to Kedrion? The biggest opportunity was to join a younger, smaller company that was at an earlier stage of development compared to a larger, more…
Novartis Belgium Mrs van der Kamp, you launched your career as a strategy consultant however, since then you have moved into the pharmaceutical industry by joining Novartis where you quickly worked your way up the ladder. What attracted you to this industry and Novartis specifically? Prior to beginning my career as a…
Herba Chemosan You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find Herba Chemosan today? Herba Chemosan was founded in 1916 as a cooperative for pharmacists and has undergone many transformations over…
Federal Public Service (FPS) Health With an expenditure of more than 10% of GDP on health, Belgium maintains one of the world’s leading healthcare systems. That said, could you please comment on the current state of the healthcare system and the governments’ key priorities with respect to health? Indeed, Belgium does boast a highly commendable…
See our Cookie Privacy Policy Here